21-23 June 2010
Montreux, Switzerland
The pharmaceutical, bio- and medical technology industry continues to morph as it succumbs to growing pressures from payers and patients. As companies move to carve out market niches with lucrative potential, their value model reverts back to a market-driven ideology where targeted specialisation will help market players regain focus and stabilise. The consolidations of 2009 showed a search for synergies and an attempt to strengthen market positions, but drug and device makers should further seek ways to capitalise on their corporate and product brand equity, in order to remain at the forefront of an increasingly crowded marketplace.
As the industry evolves from a therapy- to a service-oriented model, the customer must stand at the centre of the organisation. At the same time, virtually all health systems in the developed hemisphere are scrutinising treatment cost efficiency, while developing countries are striving to create such systems and will soon require access to therapies at prices much lower than their Western counterparts. At the PharmaBrand Summit we aim to provide the essential information and business contacts needed to bring pharmaceutical marketing into a new era of excellence.
The PharmaBrand Summit 2010 offers the perfect setting for sponsors to present their products and services directly to key decision makers from Europe’s leading pharmaceutical, bio- and medical technology companies. Over three days, sponsors will meet and interact with senior-level marketing executives, through a number of business one-to-one meetings and many networking activities. In addition, sponsors will attend the strategic summit sessions led by some of the most prominent thinkers and practitioners in Europe and beyond. Within the luxurious settings of a five star venue, this networking event presents a unique opportunity to develop meaningful and valuable business relations.
Contact:
Kirsten Helders, Marketing Manager, at summits@marcusevanscy.com
www.pharmabrandeurope.com |
